explore -WSS

explore

author：Wikipedia 2025-10-03 00:08:24 - browse：574

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits.

The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health. Novo is testing Wegovy, a weekly injection also sold under the brand name Ozempic for type 2 diabetes, against placebo in the five-year study.

The implications are massive, and not just for Novo. Wegovy is part of a class of medicines that target a hormone called GLP-1, which curbs patients’ appetites. Those drugs have demonstrated an ability to help people lose dramatic amounts of weight in clinical trials, but payers, including Medicare, have been slow to reimburse for them without definitive data on their long-term health benefits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Welsh Carson private equity firm escapes from FTC antitrust case

hotspot

WSS

Warren pushes Witty on UnitedHealth's control over physicians

Chemotherapy before breast cancer surgery might fuel metastasis

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Deliver public health messages at the right time

Welsh Carson private equity firm escapes from FTC antitrust case

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

leisure time

explore

Wikipedia

Bright Health sells Medicare Advantage business to Molina

The new HIV moral panic

Anesthesiologist group: stop taking Ozempic before surgery

Warren pushes Witty on UnitedHealth's control over physicians

Dobbs anniversary: the lost opportunity of abortion as health care

Celiac disease study examines precisely how gluten triggers injury

New air purifier tech could be key to improving indoor air quality

Primary care doctor shortage won't be solved by free med school tuition

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Grail faces three suits alleging harassment, retaliation

explore

Celiac disease study examines precisely how gluten triggers injury

Empower primary care with adequate payments and technology

Congress likely to miss an opportunity to fix drug shortages issue

The new HIV moral panic

Federal judge rules Oregon’s tough new gun law is constitutional

As billionaires fund anti

hotspot

hotspot

entertainment

hotspot